Prostate Cancer - Results from #21580

'Race' and prostate cancer mortality in equal-access healthcare systems - Abstract December 18, 2013

Prevalence and factors associated with conducting screening tests for prostate cancer in the elderly in Juiz de Fora in the state of Minas Gerais, Brazil - Abstract December 18, 2013

The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy - Abstract December 18, 2013

Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects - Abstract December 18, 2013

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator? - Abstract December 18, 2013

Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study - Abstract December 18, 2013

Diethylstilboestrol for the treatment of prostate cancer: Past, present and future - Abstract December 18, 2013

Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients - Abstract December 18, 2013

High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage T3a prostate cancer with a negative surgical margin - Abstract December 18, 2013

Robotic ultrasound and needle guidance for prostate cancer management: Review of the contemporary literature - Abstract December 18, 2013

Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases - Abstract December 18, 2013

Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: Retrospective analysis of a single institution experience - Abstract December 18, 2013

Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate - Abstract December 18, 2013

Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: Results of a randomized trial - Abstract December 18, 2013

Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival - Abstract December 17, 2013

Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer - Abstract December 17, 2013

Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer - Abstract December 17, 2013

Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer - Abstract December 17, 2013

The importance of anatomical region of local anesthesia for prostate biopsy; a randomized clinical trial - Abstract December 17, 2013

A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer - Abstract December 17, 2013

Page 1080 of 1435